Liver Cancer Diagnostics Market Overview 2024: Size, Growth Drivers, and Major Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Liver Cancer Diagnostics Market for the Period 2024 to 2033?
The market size for liver cancer diagnostics has seen robust growth in the recent past. It’s projected to expand from the current value of $9.19 billion in 2023 to reach $9.95 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 8.3%. The historical expansion of the market is credited to factors such as the refinement of biopsy techniques and histopathology, advancements in the detection of biomarkers, the introduction of better screening programs, forward strides in genetic testing, and improvements in liver imaging modalities.
The market for liver cancer diagnostics is predicted to experience robust growth in the upcoming years, ballooning to a value of $12.96 billion by 2028 with a Compound Annual Growth Rate (CAGR) of 6.8%. This positive projection for the forecast period stems from regulatory standardization, the enhanced role of imaging modalities, advancements in next-generation sequencing, broadened screening programs and awareness, plus an increased need for biomarker-based testing. The forecast period is also expected to be marked with an increase in incidence and prevalence, progress in imaging technologies, heightened emphasis on non-invasive diagnostics, precision medicine, personalized diagnostics, and the incorporation of artificial intelligence (AI)..
Claim Your Free Sample of the Global Liver Cancer Diagnostics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10481&type=smp
What Factors Are Responsible for the Growth of the liver cancer diagnostics Market?
The increase in liver cancer cases is anticipated to advance the liver cancer diagnostics market. Liver cancer is a deadly disease characterized by uncontrolled growth and multiplication of liver cells. Diagnostic tests for liver cancer play a crucial role in deciphering the spread of cancer cells within or around the liver following a primary liver carcinoma diagnosis, thereby giving a push to the liver cancer diagnostics market due to the escalating number of liver cancer cases. As an example, the Cancer Facts & Figures 2023 report put out by the American Cancer Society, a US voluntary health organization, suggested a rise in the number of new cases of liver and intrahepatic bile duct cancer in females in the US, from 12,640 cases in 2020 to 13,230 cases in 2023. Additionally, 41,210 new liver cancer diagnoses are predicted in the US in 2023, and 29,380 people are foreseen to lose their lives to it. The escalating frequency of liver cancer thus acts as the force driving the expansion of the liver cancer diagnostic market.
Which Segments Are Important for Insight into the Liver Cancer Diagnostics Market?
1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types
2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories
What Are the Significant Trends Reshaping the Liver Cancer Diagnostics Sector?
The leading trend gaining traction in the liver cancer diagnostics market is technological innovation. Key players in this market are concentrating on creating groundbreaking diagnostic technologies to maintain a competitive advantage. For example, in December 2021, pharmaceutical consultancy firm Helio Health and cancer therapeutics developer Fulgent Genetics Inc., both based in the US, introduced HelioLiver. This revolutionary liquid biopsy test can detect liver cancer at an early stage. This multi-analyte blood test is capable of identifying hepatocellular carcinoma (HCC), which is the most common type of liver cancer, by combining serum protein markers with cell-free DNA (cfDNA) methylation patterns. HelioLiver offers the potential to provide more curative treatment options, which could potentially increase five-year survival rates by as much as 13 times, compared to when the cancer has spread.
Order Now for Fast Delivery of Your Liver Cancer Diagnostics Market Report!
https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report
Which Regions Are Essential for the Growth of the Liver Cancer Diagnostics Market?
North America was the largest region in the liver cancer diagnostics market in 2023. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Liver Cancer Diagnostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the liver cancer diagnostics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Liver Cancer Diagnostics Market Include
1. Liver Cancer Diagnostics Market Executive Summary
2. Liver Cancer Diagnostics Market Segments
3. Liver Cancer Diagnostics Market Size And Template Market Growth Rate
4. Key Liver Cancer Diagnostics Market Trends
5. Major Liver Cancer Diagnostics Market Drivers
……
25. Key Mergers And Acquisitions In The Liver Cancer Diagnostics Market
26. Top Liver Cancer Diagnostics Companies
27. Liver Cancer Diagnostics Market Opportunities And Strategies
28. Liver Cancer Diagnostics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Livestock Healthcare Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/livestock-healthcare-global-market-report
Essential Oils & Plant Extract For Livestock Global Market Report 2024
Animal Growth Promoters And Performance Enhancers Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
